Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SOT113
- Development stage
- Preclinical
- Lead developer
- SOTIO Biotech AG
- Modality
- Small Molecules, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
SOT113 is a bispecific antibody-drug conjugate (ADC) being developed by SOTIO for the treatment of cancer. It is designed to enable precision targeting of prostate cancer and potentially other solid tumors. As a bispecific ADC, SOT113 combines two components: an antibody that allows highly targeted delivery to tumor cells, and a potent cytotoxic agent that directly kills those cells upon internalization. This approach aims to maximize anti-tumor efficacy while minimizing off-target toxicity[2][3][1]. The drug is in preclinical or early clinical development and represents part of SOTIO's pipeline focused on next-generation immuno-oncology therapeutics.
Beyond the preview
Go deeper on SOT113.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOT113.